A first-of-its kind clinic to coordinate care for improved outcomes.
Patients with cancer and organ transplants are being treated in silos for each of their conditions. Providers do their best, but in the typical clinical settings, coordinating care is nearly impossible.
Our Cancer and Organ Transplant Clinic is a first-of-its-kind, multidisciplinary consult clinic for organ transplant candidates and recipients with challenging cancer and transplant conditions.
Founded in 2021, it brings together physicians from the Fred Hutchinson Cancer Center and UW Medicine Transplant services to provide personalized medicine to directly improve clinical care for patients.
A novel approach to unified care
The Cancer and Organ Transplant Clinic offers in-person and telemedicine-based consultation with both cancer and transplant specialists customized for each patient, and results in a unified care recommendation for the patient and referring providers.
The clinic applies contemporary knowledge and state-of-the-art therapies from 12 cancer specialties and all organ transplant types to address patient-centered issues.
Questions this clinic addresses include:
- How long after cancer treatment is it advisable to proceed with an organ transplant?
- What are the optimal cancer and transplant therapies for transplant candidates and recipients?
Immediate, recorded recommendations
Patients seen at the Cancer and Organ Transplant Clinic benefit from a multiple-specialty consultation clinic, where a real-time tumor and transplantation board is convened during the patient visit. We share recommendations with the patient and referring providers immediately after the meeting. Plus, all patient-provider conversations are recorded, so we provide patients with a USB drive of the audio recording at the end of the visit.
Mutual benefit
Our multiple-specialty clinic offers mutual benefit to patients and researchers. Leading physicians in the fields of cancer and transplant offer the latest research knowledge to our patients, and we invite our patients to contribute to cutting-edge research that will improve the future of organ transplant and cancer care.